High alk phos, or elevated alkaline phosphatase, signals possible liver disease, bone disorders, or other systemic conditions. Levels above 120 U/L typically prompt further investigation into organ function or metabolic activity.
Alkaline phosphatase (alk phos) is an enzyme produced primarily in the liver and bones. Its presence in blood reflects cellular turnover in these tissues. When levels rise, it suggests increased release from cells-either due to damage, obstruction, or heightened activity. Normal ranges vary slightly by lab but generally fall between 40-120 U/L for adults.
Levels above 120 U/L are considered elevated. A value of 200 U/L or higher often triggers diagnostic follow-up. For example, a patient with a result of 280 U/L may have cholestasis, Paget's disease, or bone metastases. The context-age, sex, medications, and symptoms-determines whether the elevation is clinically significant.
Alk phos is measured via a standard blood draw during routine liver panels or when symptoms like jaundice, fatigue, or bone pain arise. The test uses spectrophotometry to measure enzyme activity in serum at specific pH levels. Results appear within hours to a day.
Laboratories report values in units per liter (U/L). Reference ranges differ based on age. Children and adolescents often have higher baseline levels due to active bone growth. Adults typically see levels under 120 U/L. Values exceeding 200 U/L require clinical correlation.
A 62-year-old woman with a result of 310 U/L and mild abdominal discomfort was referred for imaging. Ultrasound revealed gallstones and bile duct dilation. Her alkaline phosphatase rose due to obstructive cholestasis-a condition where bile flow is blocked. After surgery, her levels normalized to 85 U/L.
Elevated alk phos most commonly stems from liver or bone-related processes. Liver causes include cholestasis, hepatitis, cirrhosis, and drug-induced injury. Bone causes include Paget's disease, osteomalacia, fractures, and metastatic cancer.
Some medications raise alk phos, including anticonvulsants (phenytoin), antibiotics (erythromycin), and statins. Pregnancy also increases levels-up to 200 U/L in the third trimester-due to placental production.
Non-liver, non-bone causes are rarer but exist. These include hyperparathyroidism, intestinal ischemia, and certain lymphomas. A 45-year-old man with no history of liver disease had alk phos at 240 U/L. Further testing showed elevated parathyroid hormone and low calcium-diagnosed as primary hyperparathyroidism.
| Type | Common Causes | Typical Range | Associated Symptoms |
|---|---|---|---|
| Liver | Obstructive jaundice, hepatitis, cirrhosis | 120-300 U/L | Dark urine, pale stools, itching |
| Bone | Paget's disease, healing fracture, metastases | 150-500 U/L | Bone pain, deformity, elevated calcium |
| Other | Pregnancy, drugs, hyperparathyroidism | 100-250 U/L | Generalized fatigue, nausea |
When alk phos is elevated, clinicians use additional tests to determine origin. Alkaline phosphatase isoenzyme analysis separates liver, bone, intestinal, and placental forms. Bone-specific isoforms increase in skeletal disorders; liver isoforms dominate in cholestasis.
Gamma-glutamyl transferase (GGT) is a key differentiator. GGT rises with liver disease but stays normal in pure bone conditions. A patient with alk phos at 260 U/L and GGT at 180 U/L likely has liver involvement. If GGT is normal and alk phos is high, bone pathology is more probable.
I once saw a 70-year-old man with alk phos at 340 U/L and normal GGT. He reported hip pain and a history of prostate cancer. X-rays showed thickened bones and bowing of the femur-classic signs of Paget's disease. His treatment included bisphosphonates, which reduced alk phos to 110 U/L in six weeks.
Many assume high alk phos always means liver failure. That's incorrect. While liver disease is a frequent cause, bone disorders are equally common. Up to 40% of elevated alk phos cases stem from bone metabolism, especially in older adults.
Another misconception is that alk phos elevations are always pathological. Mild increases during pregnancy or in children are expected. A child with alk phos at 200 U/L may simply be growing rapidly-the enzyme supports bone mineralization. No intervention is needed unless symptoms appear.
Some patients worry about cancer when alk phos is high. While metastatic bone disease can improve levels, most cases are benign. A study in *Hepatology* found that 65% of patients with isolated alk phos elevation had non-malignant causes, including medication effects and nutritional deficiencies.
If alk phos exceeds 120 U/L, doctors assess clinical context. They review medications, past medical history, and symptom onset. Additional blood work includes AST, ALT, bilirubin, calcium, phosphate, and vitamin D levels.
Imaging such as ultrasound or CT may follow. For suspected bone disease, a bone scan or X-ray is ordered. A patient with persistent elevation despite normal liver tests may undergo a biopsy if malignancy is suspected.
For example, a 58-year-old man with alk phos at 220 U/L and normal liver enzymes underwent a bone scan. It revealed multiple hot spots in the spine and pelvis. Biopsy confirmed metastatic colorectal cancer. Early detection improved his treatment plan.